Buy or sell Vivace Therapeutics stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies
Vivace Therapeutics Stock
Vivace Therapeutics is a venture-backed start-up dedicated to discovering and developing cancer therapeutics by targeting a novel pathway.
About Vivace Therapeutics Stock
Vivace Therapeutics is a venture-backed start-up dedicated to discovering and developing cancer therapeutics by targeting a novel pathway. At Vivace Therapeutics, they pursue their work with passion, driven by a conviction to help people fight cancer and live life to the fullest. Based in the San Francisco Bay Area, Vivace Therapeutics is an oncology-focused portfolio-based drug discovery and development company adopting a capital-efficient and modality-indifferent approach to bring novel therapies to patients in need. Their experienced management team and world-class scientists work to advance promising drugs and therapeutic technologies that they believe can help conquer cancer.
Funding History
| January 2015 | $15.0M |
|---|---|
| June 2017 | $25.0M |
| December 2020 | $30.0M |
Management
President and Chief Executive Officer
Sofie Qiao
Board Member
Dr. Norman Zhou
Director Of Operations
Amy Pfeiffer
Chief Scientific Officer
Leonard Post
Vice President of Corporate Development
Tuomas Holmberg
Vice President of Biology of Vivace Therapeutics
Tracy Tang
Vice President of Chemistry
Andrei Konradi
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
